Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 31 July 2024.
This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated
1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.
2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.
3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
